Jump to any asset
850 assets, updated daily
As of September 10, 2026, Centene Corp. (CNC) trades at $65.40. CleaRank Financial AI rates it Hold with a fair value of $70.50, 7.8% above the current price. Wall Street's consensus target is $70.50 across 21 analysts. RSI at 47 is in neutral territory, and the price is below its 50-day average of $65.50.
Centene Corp. (CNC)
Centene Corp. NYSE
$65.40
1.340 (2.09%)
Latest Price
AI Analyst Consensus
59 / 100
Centene Corp. (CNC) is currently trading at $64.06, above its 200-day moving average but below its 50-day and 20-day moving averages, indicating a mixed technical picture. The company's consensus rating is 'Hold' with a score of 62, supported by 21 analysts, with a median price target of $70.50 suggesting a modest 10.1% upside potential. Recent earnings have shown mixed results, with a notable beat in the most recent quarter but a pattern of volatility in prior periods. The company is facing headwinds with projected revenue declines in the current and next quarters. Fundamental analysis reveals that Centene Corp. operates within the Healthcare Plans industry. While its current valuation metrics are not directly comparable due to negative EPS, the company's revenue growth has been modest. The sector averages indicate a more strong growth environment, suggesting CNC may be underperforming its peers in terms of top-line expansion. Key risks include the moderate insider selling trend and the projected revenue contraction, which could pressure future profitability and growth prospects.
CNC Price Analysis
Market Metrics
Open
$65.50
Day Range
$65.33 to $68.21
Prev Close
$64.06
Volume
4.62M
52-Week Range
$28.24 to $69.36
Market Cap
$31.65B
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
Trading at a notable discount to sector peers (-68%), which may indicate undervaluation or specific company headwinds.
CNC Financial Performance
Revenue vs. Earnings
Annual
Quarterly
Earnings Reality Check
Analysis: In the last 3 quarters, CNC beat estimates 3 times. The stock rose 2 times the next day. Price tends to react positively to beats.
CNC Analysis
Company's Health
3/5
12-Month Analyst Target
+7.80% Upside
Median of 21 analysts (12-month)
$70.50
AI Technical Analysis
Centene Corp. (CNC) exhibits neutral momentum with an RSI of 47.32, indicating neither overbought nor oversold conditions. The stock is trading below its 50-day SMA of $65.50 and its 20-day EMA of $65.44, suggesting short-term weakness, although it remains above its 200-day SMA of $50.61. MACD is slightly positive at 0.178, hinting at a potential shift but lacking strong conviction. Volume has been slightly above average recently, with the latest volume at 4.48 million compared to an average of 4.33 million. The chart structure indicates that the 50-day SMA is acting as resistance, while the 200-day SMA is providing support. The current price action suggests a period of consolidation or a potential downtrend initiation if the 200-day SMA is breached. Investors should monitor the 50-day SMA closely as a key level to watch for a potential shift in short-term momentum.
ProTips
- Monitor upcoming earnings reports closely for any signs of revenue stabilization or growth reversal, as this is a key factor for Centene Corp.'s (CNC) future performance.
- Given the 'Hold' consensus and limited upside to the median price target, consider waiting for a clearer bullish signal or a more attractive entry point before initiating a significant position in CNC.
- The moderate insider selling trend at Centene Corp. (CNC) warrants attention; a significant increase in insider purchases could signal renewed confidence from management.
Key Catalysts
Bearish
Projected Revenue Declines
Centene Corp. (CNC) is forecasting revenue decreases in the current quarter (-6.00% YoY) and next quarter (-9.00% YoY), indicating potential market share loss or pricing pressures.
Source: Wall Street Revenue EstimatesBearish
Moderate Insider Selling
Insiders have sold a net of over $14 million in Centene Corp. (CNC) stock, with total sales significantly outweighing total purchases, signaling potential concerns from management.
Source: Insider SummaryBullish
Positive Earnings Surprise in Latest Quarter
Centene Corp. (CNC) beat EPS estimates by 6.02% in its most recent reported quarter, demonstrating an ability to outperform analyst expectations.
Source: Earnings RecentNeutral
Trading Above 200-Day Moving Average
Centene Corp. (CNC) is currently trading above its 200-day SMA of $50.61, indicating a longer-term upward trend remains intact despite recent choppiness.
Source: Technical AnalysisMarket Outlook
Centene Corp. (CNC) is expected to navigate a challenging period in the next 6-12 months, with a base case scenario reflecting its current 'Hold' consensus and limited upside to the median analyst target of $70.50. The projected revenue declines in the near term will likely temper significant stock appreciation, and the company will need to demonstrate a clear path to reversing this trend to attract stronger investor sentiment. The current trading price of $64.06 suggests that the market is pricing in some of these headwinds. Potential catalysts for upside include a stronger-than-expected earnings performance that reverses the negative revenue trajectory or a significant improvement in the company's competitive positioning within the healthcare market. Conversely, continued revenue contraction, persistent insider selling, or a deterioration in the company's profitability could push the stock towards its downside targets. Investors should monitor upcoming earnings reports and management commentary for signs of a turnaround.
Key Statistics
| Market Cap | 31.65B |
|---|---|
| P/E Ratio | N/A (Negative EPS) |
| EPS (TTM) | -10.36 |
| Dividend Yield | 0.00% |
| 52 Week High | 69.36 |
| 52 Week Low | 28.24 |
Centene Corp. (CNC) presents a complex fundamental picture, with a negative EPS of -10.36 rendering traditional P/E ratio analysis impossible. The company's revenue growth stands at 4.6%, which lags behind the sector average of 10.00%. This slower top-line expansion, coupled with projected revenue declines in the upcoming quarters, raises concerns about the company's ability to grow effectively within the competitive healthcare landscape. The market capitalization of $31.65 billion indicates a large-cap entity, but its current financial trajectory requires careful scrutiny. The negative EPS suggests profitability challenges. The sector averages for ROE (15.00%) and P/S (4.20) provide a benchmark, but CNC's current performance metrics do not align favorably. Investors should focus on the company's ability to reverse its revenue decline and improve its earnings to justify its current market valuation.
Earnings & Growth Analysis
Centene Corp. (CNC) has demonstrated a volatile earnings history, with the most recent quarter ending July 23, 2026, showing an EPS of $3.52, beating estimates by 6.02% but resulting in a slight price decrease of -0.52%. Prior quarters show a significant beat in April 2026 ($3.37 actual vs. $2.13 estimate, +58.22% surprise) and an even larger beat in March 2026 ($0.15 actual vs. $0.06 estimate, +150% surprise), followed by a price drop of -3.82%. However, the quarter ending May 29, 2026, saw a beat of 24.32% with a positive price reaction of 4.03%. This inconsistency in performance and market reaction suggests that investors may be hesitant to price in sustained earnings strength.
Key Risks
Centene Corp. (CNC) faces significant risks stemming from moderate insider selling, with total sales exceeding purchases by over $14 million. Also, the company is projecting revenue declines in the current and next quarters, indicating potential headwinds to top-line growth. The inconsistent earnings performance and mixed analyst sentiment also contribute to uncertainty regarding the company's future trajectory.
Technical Indicators
| RSI (14) | 47.32 |
|---|---|
| MACD | 0.18 |
| SMA 50 | 65.50 |
| SMA 200 | 50.61 |
RSI
Neutral
SMA Cross
Bullish
Price vs SMA
Bearish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($65.50) above the 200-day SMA ($50.61), price is trading below the 50-day SMA.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.05
Weak correlation
Nasdaq 100 (QQQ)
+0.01
Weak correlation
Bitcoin (BTC)
+0.08
Weak correlation
Gold (XAU)
-0.03
Weak correlation
Check Custom Correlation
Calculating correlation...
CNC Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies (click to switch)
CONSERVATIVE
$64.75
Slight discount to current
Wait for small dip
AGGRESSIVE
$65.40
At current price
Enter now if confident
Risk Management
STOP LOSS
$60.21
MAX LOSS
-7.0%
Volatility-Adjusted Stop Loss
Calculated based on RSI (47.3) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$66.69
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$67.98
+5% (Conservative)
+4.0% (Aggressive)
TARGET 3
$69.93
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for CNC is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 11, 2026.Growth of $10,000
A $10,000 investment in CNC in September 2016 would be worth about $18,830 today, compared with about $35,241 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CNC today could grow to about $19,389 by 2036 in the base case, with a bull case near $98,449 and a bear case around $3,818. Projections are statistical simulations, not guarantees.
CNC Stock Price Prediction: 2030
CleaRank's simulation projects a price near $85.23 for CNC by 2030 in the base case, from $65.40 today (1.3x over 4 years). The downside path ends near $30.50. These are outcomes of a Monte Carlo simulation run on CNC's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $41.80 | $69.88 | $117 |
| 2028 | $36.10 | $74.66 | $154 |
| 2029 | $32.76 | $79.77 | $194 |
| 2030 | $30.50 | $85.23 | $238 |
| 2031 | $28.86 | $91.06 | $287 |
| 2032 | $27.64 | $97.30 | $343 |
| 2033 | $26.70 | $104 | $405 |
| 2034 | $25.97 | $111 | $475 |
| 2035 | $25.40 | $119 | $554 |
| 2036 | $24.97 | $127 | $644 |
Method: 10,000 simulated price paths using CNC's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
CNC Insider Trading Analysis
Bought
$738.9K
2 Transactions
Sold
$14.6M
4 Transactions
Insiders
18
Active Traders
Avg Transaction
$2.6M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Nov 9, 2020 | NEIDORFF MICHAEL F
Chief Executive Officer
|
Sell | 300.0K | $21.0M |
| Jun 10, 2026 | BURDICK KENNETH A
Director
|
Sell | 80.0K | $5.2M |
| Dec 14, 2021 | NEIDORFF MICHAEL F
Officer and Director
|
Sell | 50.0K | $4.0M |
| Aug 26, 2026 | KOSTER CHRISTOPHER A.
General Counsel
|
Sell | 56.5K | $3.8M |
| Aug 18, 2026 | KOSTER CHRISTOPHER A.
General Counsel
|
Sell | 47.6K | $3.1M |
| Dec 4, 2025 | BURDICK KENNETH A
Director
|
Sell | 66.0K | $2.6M |
| Nov 9, 2020 | BURDICK KENNETH A
Officer
|
Sell | 35.0K | $2.5M |
| May 11, 2020 | BURDICK KENNETH A
Officer
|
Sell | 35.0K | $2.3M |
| Apr 30, 2020 | BURDICK KENNETH A
Officer
|
Sell | 35.0K | $2.3M |
| Jul 30, 2020 | BURDICK KENNETH A
Officer
|
Sell | 35.0K | $2.3M |
Page 1 of 1
Frequently Asked Questions
What is Centene Corp.'s consensus rating and score?
Centene Corp. (CNC) currently holds a 'Hold' consensus rating with a consensus score of 62 out of 100, based on the analysis of 21 Wall Street analysts.
What is the median analyst price target for Centene Corp. stock?
The median analyst price target for Centene Corp. (CNC) is $70.50, which represents an upside of approximately 10.10% from its current trading price of $64.06.
How has Centene Corp. performed in its recent earnings reports?
Centene Corp. (CNC) reported an EPS of $3.52 for the quarter ending July 23, 2026, beating estimates by 6.02%, though the stock saw a minor decline. Prior quarters showed significant EPS beats, but with varied price reactions, indicating inconsistent investor sentiment towards earnings.
What are the key risks facing Centene Corp.?
Key risks for Centene Corp. (CNC) include moderate insider selling totaling over $14 million and projected revenue declines in the upcoming quarters, which could impact future profitability and growth.
Is Centene Corp. stock a buy right now?
Centene Corp. (CNC) is currently rated as a 'Hold' by Wall Street analysts, with a median price target suggesting limited upside. While the stock trades above its 200-day moving average, it is below its shorter-term moving averages, and faces risks from declining revenue projections and insider selling, making it a neutral prospect at this time.
What is the revenue growth outlook for Centene Corp.?
Centene Corp. (CNC) is projected to experience revenue declines in the current quarter (estimated -6.00% year-over-year) and the next quarter (estimated -9.00% year-over-year). For the current year, revenue growth is estimated at +1.00%, with a slight contraction expected next year.
How does Centene Corp.'s valuation compare to its sector averages?
Centene Corp. (CNC) has a negative EPS, making direct P/E comparison difficult. Its reported revenue growth of 4.6% is below the sector average of 10.00%, suggesting it is growing at a slower pace than its peers in the Healthcare sector.
What is CNC's stock forecast for 2030?
Based on Monte Carlo simulations, Centene Corp.'s (CNC) stock forecast for 2030 shows a base case price of $83.48, with a downside projection of $29.87 and an upside projection of $233.3. These figures represent simulation outcomes, not guaranteed price targets.